BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $35,082,000 | +5.7% | 436,180 | +5.8% | 1.20% | +12.7% |
| Q2 2021 | $33,189,000 | +13.5% | 412,283 | +18.9% | 1.07% | +4.9% |
| Q1 2021 | $29,238,000 | -73.1% | 346,674 | -77.7% | 1.02% | -33.3% |
| Q2 2015 | $108,581,000 | -2.4% | 1,552,714 | -4.4% | 1.52% | -5.6% |
| Q1 2015 | $111,271,000 | -3.1% | 1,624,400 | +3.6% | 1.62% | -7.6% |
| Q4 2014 | $114,880,000 | +22.4% | 1,567,469 | +19.8% | 1.75% | +30.1% |
| Q3 2014 | $93,871,000 | -5.5% | 1,307,936 | -4.8% | 1.34% | -3.3% |
| Q2 2014 | $99,377,000 | -3.2% | 1,374,512 | -1.5% | 1.39% | -8.6% |
| Q1 2014 | $102,702,000 | +3.3% | 1,395,787 | -2.4% | 1.52% | +3.6% |
| Q4 2013 | $99,431,000 | +6.6% | 1,429,638 | +0.7% | 1.47% | -3.9% |
| Q3 2013 | $93,241,000 | -10.9% | 1,419,402 | -6.1% | 1.53% | -9.7% |
| Q2 2013 | $104,703,000 | +27.9% | 1,511,523 | +34.1% | 1.69% | +29.1% |
| Q1 2013 | $81,893,000 | – | 1,127,386 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |